Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-19 6:58:16 pm | TPST Stock Earnings: Tempest Therapeutics Beats EPS for Q4 2023 | InvestorPlace |
| 2024-03-19 1:25:0 pm | Tempest Reports Year End 2023 Financial Results and Provides Business Update | GlobeNewswire |
| 2024-03-12 5:0:0 am | Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types | GlobeNewswire |
| 2024-03-05 1:30:0 pm | Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting | GlobeNewswire |
| 2024-02-26 5:0:0 am | Tempest to Present at the 44th Annual TD Cowen Healthcare Conference | GlobeNewswire |
| 2024-02-02 1:30:0 pm | Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information